In 2020, a routine checkup turned into a high-stakes race when Tad Ihns was diagnosed with fast-moving basal cell carcinoma. The surgical intervention saved him, but as an engineer used to mission-critical sensors, he was stunned to find that skin cancer detection still relies on flat, 2D snapshots. He realized that "good enough" imaging leaves clinicians blind to the "iceberg" beneath—the volumetric depth and structural density that define a lesion's true risk.
Driven by the gaps in his own care, Tad pivoted from defense optics to a new, singular mission: to eliminate clinical uncertainty. By fusing 3D spatial modeling with multi-spectral insight, Lumijes is leading the way with advanced technology he wished his doctors had—turning invisible risks into the visual clarity that saves lives.
